CardioNet Defies Prior Secondary Trends (BEAT)
CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold 5 million shares at a price of $26.50 per share. All shares were being sold by selling shareholders and the…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold 5 million shares at a price of $26.50 per share. All shares were being sold by selling shareholders and the company itself will realize no proceeds from the sale of these shares.
Citigroup was the sole book-runner and co-managers were Banc ofAmerica, Leerink Swann, Thomas Weisel, and Cowen & Co. Shares areup at $28.19 today on more than 1.2 million shares. This stock hastraded between $26 and $30 for almost all of the last month and shareswere under $20.00 back in April.
Hmm. Insiders and backers selling after a large run when the markethas been challenged. That’s not necessarily a red flag but it also isn’t exactly aringing endorsement for tomorrow. Usually this much discounting for a secondary where the company gets no benefit after a large run up has more consequences. Perhaps the company’s niche is offering it some protection.
Jon C. Ogg
August 1, 2008
Contact [email protected] for any questions or corrections.